X4 Pharmaceuticals (XFOR) Price to FCF (2019 - 2026)
X4 Pharmaceuticals' (XFOR) quarterly Price to FCF came in at 28.37 in Q2 2026, down 5508.29% on a YoY basis from 0.52 in Q2 2025, and down 6.6% quarter-over-quarter from 26.61 in Q1 2026.
Powered by 
Analysis
X4 Pharmaceuticals (XFOR) Price to FCF (2019 - 2026) Analysis & Trends
X4 Pharmaceuticals (XFOR) has reported Price to FCF for 8 consecutive years, with 28.37 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Price to FCF fell 5508.29% year-over-year to 28.37; the trailing twelve-month figure through Jun 2026 stood at 7.0 (down 4961.13% YoY), and the FY2025 full-year result was 1.96, down 110.53% from the prior year.
- Price to FCF eased to 28.37 in Q2 2026 per XFOR's latest filing, from 26.61 in the prior quarter.
- Across five years, Price to FCF topped out at 0.51 in Q2 2025 and bottomed at 247.79 in Q1 2024.
- Historically, Price to FCF has averaged 75.03 across 5 years, with a median of 50.13 in 2022.
- The sharpest annual moves came in 2025 and 2026: Price to FCF jumped 99.02% in 2025, then plunged 5508.29% in 2026.
- Over 5 years, Price to FCF stood at 98.94 in 2022, then slumped by 62.72% to 161.0 in 2023, then surged by 97.64% to 3.8 in 2024, then slumped by 177.87% to 10.56 in 2025, then plunged by 168.59% to 28.37 in 2026.
- According to Business Quant data, Price to FCF over the past three periods registered 28.37, 26.61, and 10.56 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn |
| 10 | X4 Pharmaceuticals | 510.43 Mn | 315.33 Mn | 7.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -28.37 |
| Mar 31, 2026 | -26.61 |
| Dec 31, 2025 | -10.56 |
| Sep 30, 2025 | -5.32 |
| Jun 30, 2025 | -0.51 |
| Mar 31, 2025 | -3.32 |
| Dec 31, 2024 | -3.80 |
| Sep 30, 2024 | -3.31 |
| Jun 30, 2024 | -51.79 |
| Mar 31, 2024 | -247.79 |
| Dec 31, 2023 | -161.00 |
| Sep 30, 2023 | -78.27 |
| Jun 30, 2023 | -199.74 |
| Mar 31, 2023 | -120.27 |
| Dec 31, 2022 | -98.94 |
| Sep 30, 2022 | -182.56 |
| Jun 30, 2022 | -48.47 |
| Mar 31, 2022 | -79.87 |
| Dec 31, 2021 | -101.35 |
| Sep 30, 2021 | -275.54 |